Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903885 · ClinicalTrials.gov registry record · NA
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
A NA study of Colorectal Cancer and Prevention, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
- 2
- Study locations
NCT05903885 is a NA study of Colorectal Cancer and Prevention that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 1,200 participants, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (20% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05903885, a NA study of Colorectal Cancer and Prevention, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
- 2
- Study locations
Study Summary
African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits to the DMV, 4606 N 56th St Ste100, Omaha, for CRC screening. All participants will receive a free Fecal Immunochemical Test (FIT) kit with a prepaid return envelope, a culturally tailored educational brochure, reminder text messages and calls, and post-FIT navigation support for participants with positive results or without family doctor/insurance. Kits are returned to a designated Nebraska Medicine lab for testing, and test results will be mailed to participants within 14-21 days. Participants will be assigned to one of two groups: the on-site distribution group or the on-site distribution group with social media advertising group. The social media advertising group will additionally be exposed to targeted ads on platforms like Facebook, Instagram, and YouTube to increase awareness and potentially improve participation rates. The study will compare FIT kit return rates, positive screening rates, and completion rates of follow-up colonoscopies after positive FIT results between the two groups.
Conditions Studied
Interventions
- OTHER On-site Fecal Immunochemical Test (FIT) Kit Distribution
- OTHER On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution
Study Locations (2)
Nebraska
- Department of Motor Vehicles (DMV) - Omaha
- Douglas County Treasurer's Office - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05903885
The ClinicalTrials.gov registry entry for NCT05903885 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (20% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which On-site Fecal Immunochemical Test (FIT) Kit Distribution is the first listed.
NCT05903885 reports 2 study locations spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT05903885 about?
NCT05903885 is a clinical study titled "A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans". African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits ...
What is the current status of trial NCT05903885?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2023-10-02. Estimated completion is 2026-10.
What conditions does trial NCT05903885 study?
This clinical trial studies the following conditions: Colorectal Cancer, Prevention.
What interventions are being tested in trial NCT05903885?
The interventions under investigation include: On-site Fecal Immunochemical Test (FIT) Kit Distribution (OTHER), On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit Distribution (OTHER).
Who is sponsoring clinical trial NCT05903885?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05903885 being conducted?
This trial has 2 study locations across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.